Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New European cancer figures for 2004 - cancer experts say major efforts needed against the big four killers

17.02.2005


There were nearly 2.9 million new cases of cancer and more than 1.7 million cancer deaths in Europe last year, according to new estimates in a report published today (Thursday 17 February) in Annals of Oncology [1]. The authors warn that the ageing of the European population means that these figures will continue to rise, even if incidence and mortality rates for specific age groups remain constant.



They also say that it is vital to make a major assault on the four biggest killers – lung, colorectal, breast and stomach cancer – if there is to be quick, significant progress against the burden of the disease.

The report has been produced by Professor Peter Boyle, Director of the International Agency for Research on Cancer (IARC) from Lyon, France and Dr Jacques Ferlay, staff scientist at the Descriptive Epidemiology Unit, IARC.


Close to 3 million new cases a year

They estimated that there were nearly 2.9 million new cases diagnosed in 2004 and over 1.7 million deaths from cancer. Of these, 54% of the new cases (1,534,700) and 56% of deaths (962,600) were among men. The 25 EU countries accounted for 2 million of these new cases and 1.2 million of these deaths[2] .

"It is clear that despite a fall in stomach cancer rates and some progress in screening and treatment, cancer remains an important public health problem throughout Europe", said Professor Boyle.

Lung and colorectal cancers leading cancers overall

Overall, lung cancer was the commonest form of cancer diagnosed (13.2%) and of cancer death (20%). Although colorectal cancer was almost equally common (13%), it represented a smaller proportion of deaths (11.9%).

Breast cancer on the rise, stomach cancer decreasing

Among women, breast cancer was by far the most common, representing 27.4% of all female cases and it was also the biggest killer with nearly 130,000 deaths – 17.4% of the total. One cancer in eight in Europe was breast cancer and this form of cancer represented 7.6% of all cancer deaths. Stomach cancer rates are falling in all countries, but this still accounts for 5.9% of all new cases and 8.1% of all cancer deaths.

The major cancers in men are lung and prostate

In men, lung cancer was the commonest form of cancer, followed by prostate cancer (238,000 new cases, representing 15.5% of cancers diagnosed in men). It is worth noting that prostate cancer was the commonest form of cancer diagnosed in men in 2004 in the European Union.

Said Professor Boyle: "Lung, colorectal and breast cancer account for two-fifths of the entire European cancer total and lung, colorectal, stomach and breast cancers together are responsible for half of all the cancer deaths.

"Our estimates give a good indication of the burden of cancer incidence and death throughout Europe and will help to clarify the priorities for cancer control action."

Improvements in breast cancer screening, but slow progress for colorectal cancer prevention

"While prospects are encouraging as regards screening for breast cancer in terms of mortality reduction, progress is too slow concerning colorectal cancer prevention", said Peter Boyle. "Progress is only possible through a joint European effort", he added.

Cigarette toll heaviest on men, but increasingly also in women

The overwhelming majority of lung cancer is caused by tobacco smoking and tobacco control was clearly a number one priority, aimed not only at men, but also increasingly at women. "There has been substantial progress among men in Europe, but the situation among women – and especially young women – is cause for concern. There is also a great difference between Northern Europe and Central and Eastern Europe. Central and Eastern Europe should be a special target for tobacco control."

Mortality trend on the decrease overall

"During the Europe Against Cancer Programme, downward trends in mortality for several common cancer killers were established and that trend looks set to continue", Boyle predicted, "although there were worrying exceptions, including lung cancer in women and most common forms of cancer in Spain and Portugal."

Call for concerted action

He concluded: "To make great progress quickly it is evident that we need to make a concerted attack on the big killers – lung, colorectal, breast and stomach cancer." "IARC is particularly well-positioned to take the lead in this battle, where international coordination of efforts will be key to achieving any reduction of disease burden and of mortality through concerted prevention efforts", Peter Boyle concluded.

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. Its mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The mandate of the World cancer research Agency is to coordinate international research to take advantage of synergies and and disseminate scientific information through publications, meetings, courses, and fellowships.

[1] Annals of Oncology is the monthly journal of the European Society for Medical Oncology. Please acknowledge the journal as the source in any reports.

Cancer incidence and mortality in Europe, 2004. Annals of Oncology. doi: 10.1093/annonc/mdi098. A pdf version of the research paper with detailed results is available from Margaret Willson (details below).

[2] The European Union comprises Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, The Netherlands and United Kingdom. Europe comprises the European Union countries plus Albania, Belarus, Bosnia Herzegovina, Bulgaria, Iceland, Liechtenstein, Macedonia, Moldova, Norway, Romania, Russian Federation, Serbia and Montenegro, Switzerland and Ukraine.

Margaret Willson | alfa
Further information:
http://www.mwcommunications.org.uk
http://www.annonc.oupjournals.org
http://www.esmo.org

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>